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A B S T R A C T
Objective: This essay discusses applying the Conceptual Framework for Patient and Family Engagement to
partnerships with patients and consumers to increase their use of research evidence in healthcare
decisions. The framework’s foundational principles hold that engagement occurs on a continuum across
all levels of healthcare—from direct care to policymaking—with patients and healthcare professionals
working in full partnership and sharing responsibility for achieving a safe, high-quality, efﬁcient, and
patient-centered healthcare system.
Discussion: Research evidence can serve as a critical decision-making tool in partnerships between
patients and health professionals. However, as the framework suggests, without patient and consumer
engagement in the design, planning, interpretation, and dissemination of research ﬁndings, it is unlikely
that the broader consumer population will ﬁnd research evidence useful, much less use it, to guide their
healthcare decisions. Understanding what factors inﬂuence patient and consumer engagement can lead
to effective strategies that enable meaningful partnerships between patients and researchers.
Conclusion: Understanding patient and consumer perspectives of research evidence is critical to engaging
them in meaningful partnerships that produce actionable research ﬁndings that they can in turn use in
partnership with health professionals to improve their own health and the healthcare system as a whole.
ã 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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In 2013, Health Affairs published a conceptual framework
designed to unify and guide diverse stakeholders in the emerging
ﬁeld of patient and family engagement [1]. The framework (Fig. 1)
was built through the collaboration of clinicians, funders, patients,
caregivers, administrators, medical educators, and policymakers
committed to bringing patient and family voices not just to direct
care decisions but to healthcare organizational design, governance,
and public policy and used in various efforts to advance patient and
consumer engagement [2,3]. The framework also served as the
basis for the US Agency for Healthcare Quality and Research’s
(AHRQ) Guide to Patient and Family Engagement in Hospital Quality
and Safety [4] and the Roadmap for Patient and Family Engagement
in Healthcare Practice and Research[5] funded by the Gordon and
Betty Moore Foundation in the US.
We believe the conceptual framework provides practical and
important insights about how to engage patients and consumers in
the use of research evidence. In this essay, we identify the* Corresponding author.
E-mail address: tworkman@air.edu (T.A. Workman).
http://dx.doi.org/10.1016/j.pec.2016.07.009
0738-3991/framework’s key principles for patient and family engagement and
apply them in the context of building patient-researcher partner-
ships to increase use of evidence. We then focus on factors
inﬂuencing engagement to explore potential pathways to increas-
ing meaningful partnerships among patients, consumers, and
researchers, and other health professionals.
2. Engagement is a means not an end
In the conceptual framework, patient and family engagement is
deﬁned as: Patients, families, their representatives, and health
professionals working in active partnership at various levels across
the health care system—direct care, organizational design and
governance, and policymaking—to improve health and healthcare.
This deﬁnition identiﬁes the ultimate object of engagement as
the development of a collaborative partnership between patients
(including families) and consumers and health professionals. The
deﬁnition also implies that the end purpose of this relationship is
to improve healthcare and health outcomes for both individuals
and society. Ultimately, a partnership between patients and health
professionals—whether they be clinicians, administrators, support
staff, policymakers, or researchers—should lead to improvements
ranging from better patient outcomes, improved population
Fig. 1. A multilevel framework for engaging patients and consumers in evidence.
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societal resources. Engagement—and the partnership it creates—in
and of itself is never the end goal. Instead, collaborative partner-
ships between patients and health professionals are an essential
ingredient of improved care and health.
Deﬁning engagement relationally also is important because it
clariﬁes the problematic nature of consumer engagement with
research evidence as a goal or outcome. Under the framework’s
deﬁnitional focus on partnership, we better understand that
patients or consumers are not able to partner with research
ﬁndings, but rather with those who fund, conduct, disseminate, or
utilize such evidence. From this perspective, research evidence is
better viewed as an essential tool for patients, in partnership with
health professionals, to improve healthcare and health. Sadly, this
perspective of evidence is rarely presented to patients and
consumers or encouraged in our current system of care.
The conceptual framework emphasizes that engaged patient/
consumer-professional partnerships are needed across all levels—
at the point of care, in healthcare organization design and
governance, and in public policymaking. However, our review of
patient and family engagement conceptualizations and activitiesfound the majority focused only on the direct care setting [6]. This
is certainly understandable, given that direct care is the most
obvious patient/consumer connection to healthcare [2,7,8]. How-
ever, this renders engagement practices to little more than good
communication skills: engaged patients should ask questions,
come prepared with information, and articulate their preferences
and values, while clinicians should be engaging and empathetic,
able to listen without interrupting, offer clear advice, and answer
questions.
Focusing engagement solely on patient and provider behavior
ignores that much of what happens in the direct care setting is
shaped by policies and procedures (and culture) of the provider’s
organization as well as public policies governing providers (and
payers). Engaging patients and consumers at the organizational
design and governance and public policy levels can yield better
systems to support patient engagement in direct care [6]. Adding in
a shared value of using research evidence to create and operate
such systems ideally will yield better decisions at all levels.
Similarly, most conceptualizations of patient/consumer use of
research evidence focus solely on guiding clinical decisions about
individual care. This perspective, however, limits the partnership
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series of public forums across the United States, we engaged more
than 1200 citizens in discussions about their views on appropriate
and acceptable ways to use research evidence. Many initially
expressed individualistic perspectives on one of several case
studies of individual and community-based decisions; they were
concerned about limits on their individual rights and access to
care. However, when enabled by research evidence about longer-
term outcomes—the risks to the public posed by antibiotic overuse,
for example—their individualistic perspectives often changed.
Participants recognized the need for relevant research evidence to
help make decisions that impact the larger community and
healthcare system as a whole [9].
3. Research engagement as a pathway to increased evidence use
Although there is scant research on patient and consumer
exposure to and satisfaction with research evidence, several
studies indicate that both the perceived access and usefulness of
existing research evidence for consumers is limited [10]. One
solution is to engage patients and consumers in the research
process itself through partnerships with researchers. Such efforts
are underway in the US with the work of the Patient-Centered
Outcomes Research Institute (PCORI), which requires active
involvement of patients and caregivers, along with other end-
users, as a condition for research funding [11]. Similar efforts in the
US to create patient-researcher partnerships have been or are
being explored at AHRQ and the Food and Drug Administration
[12]. Likewise, the desire for useful evidence for patients and
health professionals is a key motivation for the creation and rapid
expansion of patient-powered research networks [13]. While
research partnerships likely have value in all types of biomedical
research, most documented efforts relate to engagement in
comparative effectiveness research (CER) and patient-centered
outcomes research (PCOR) as these are focused on providing
evidence to inform treatment decisions [14].
Across these and other efforts, patient and consumer partner-
ships in the research process take many forms, with patients and
consumers partnering in [15]:
 The study, analysis, and conclusions of research that produces
evidence.
 The translation of evidence.
 The dissemination and diffusion of evidence.
 The application of evidence in the decision-making process.
 Efforts to address knowledge gaps and evidence uncertainty.
 The development of new forms of research, evidence-
generation, and evidence-synthesis.
 Creating a culture where evidence-based decision making is
the foundation of healthcare.
While full patient engagement in research is relatively new,
early assessments suggest that research partnerships have begun
to yield beneﬁts ranging from improved relevance of research for
patients to increased research adoption by both patients and
providers [16–18]. These beneﬁts may be underreported, however,
as few studies have measured the impact of patient engagement
formally [19], particularly regarding the outcome of increased
patient and consumer use of research generated through such
partnerships.
4. Recognizing engagement as a continuum
Early assessments of patient/consumer partnerships in re-
search, however, highlight the challenge of creating robust
partnerships. Our conceptual model suggests that patient and
consumer engagement occurs in varying degrees across a
continuum, rarely moving to the degree of full partnershipenvisioned in the conceptual framework. Full partnership, as
conceived by the model, involves shared leadership—where
patients and families make decisions equally with health
professionals and researchers, sharing responsibility for the
planning, conduct, interpretation, dissemination, and adoption
of research ﬁndings. We believe this is the ultimate goal of patient/
consumer engagement and is most likely to yield the greatest
progress toward a safe, high-quality, efﬁcient, and patient-
centered system. It is not, however, the norm, and so it is
important to distinguish this degree of engagement with its lesser
forms across the continuum, and then apply this understanding to
patient/consumer use of research evidence.
On the opposite end of the engagement continuum is
consultation. Here, the patient/consumer is involved merely in a
reactive role—being provided information or providing feedback
but not directly involved in decisions (or even how the feedback is
received). Most consultative engagement occurs in isolation and is
disconnected from ongoing relationships. It is an information
exchange at best. Many healthcare activities employ this degree of
engagement, and most efforts to engage patients and families in
the use of research evidence fall on this side of the continuum. For
example, most evidence-based decision support tools are available
to patients and family members but are rarely used in a discussion
with a clinician [20–22]. Patients and families may be informed
about research ﬁndings, and how policies or formularies have been
developed as a result of research, but have no opportunity for input
on the decisions and remain passive receivers rather than active
participants.
Consultation with patients and consumers occurs often in
research. Patients may be informed about a study’s research
questions, protocol, recruitment activities, and ﬁndings but are not
asked for input and are not part of the decision-making process. A
patient or consumer may be encouraged to share research ﬁndings
with others but has no role in planning or conducting the research
or interpreting the ﬁndings.
In the middle of the continuum is involvement. Here, patients
and consumers are invited to give input or feedback, and they may
even be asked to participate in a speciﬁc role, but they are still not
engaged in shared decision making and are often unaware of how
their input shaped the ﬁnal decision. In direct care, for example, a
patient with hypertension may share their preferences for limiting
the number of medications they take. The clinician takes the input
under advisement when determining the treatment plan [1], but
prescribes antihypertension medication, communicating that it is
an essential treatment for hypertension. In policymaking, citizens
may be asked to comment on a proposed policy but are separated
from the actual decision event and often remain unaware of how
their comments inﬂuenced ﬁnal policy [1].
In the same vein, patient-consumer involvement with research
often involves serving as “key informants” to provide feedback on
research questions, protocols, reports, or dissemination products
while remaining disconnected to the actual decisions about these
issues [18,19]. Many patient “partners” are given speciﬁc tasks to
assist the research team, such as recruiting patients as subjects in a
clinical trial or helping to disseminate study ﬁndings to online
patient communities. In some cases, these roles easily move to full
partnership as patients help design inclusion and exclusion
criteria, study recruitment plan, or subject consent forms, or
participate in the interpretation and translation of ﬁndings. But
often, researchers maintain decision making separate from
patients and consumers, limiting their shared leadership [24].
Consultation and involvement are forms of engagement distinct
from partnership, where the clinician, policymaker, or researcher
shares leadership with patients and consumers to integrate their
preferences and values (along with research evidence) into the
matter at hand. While there may be appropriate uses of other
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partnership offers the greatest opportunity to reap the beneﬁts of
engagement through improved outcomes. However, striving for
full partnership requires a paradigm shift and organizational,
structural, and cultural changes to remove barriers that prevent
patients from engaging fully in the research and healthcare
improvement process [23].
5. Factors inﬂuencing engagement
For research evidence to be embraced and used by patients and
consumers as they partner with professionals to improve care and
health, several factors inﬂuencing patient engagement must be
addressed. In our conceptual model, we outline three factors—
patient, organizational, and societal—with the greatest inﬂuence
on creating vibrant partnerships.
Patient and consumer factors impact both the capacity and
motivation to engage in partnerships across healthcare levels, as
well as using research evidence as a tool in these partnerships.
There is a patient’s level of activation, which Judy Hibbard
describes as a combination of self-efﬁcacy and health literacy,
among other things [24]. But there are also cultural beliefs about
relying on experts to know the research evidence research rather
than seeking research information directly. While these beliefs are
changing as research information becomes more accessible
[25,26], PCORI survey data indicate, however, that most patients
and consumers remain unfamiliar with CER, the type of research
most likely to assist them with treatment decisions [10]. This is
likely due in part to their limited exposure to the research process
and enterprise. Often, research ﬁndings are communicated as
knowledge without details of a study’s design or data used to
determine the ﬁnding, and the public is often wary when hearing
new ﬁndings that seem to reverse older discoveries without a clear
understanding of what changes in the study’s protocol, data, or
analysis created the change. One example is the conﬂicting
research on Vitamin E [27].
Engaging patients and families as partners in disseminating and
communicating evidence often hits a snag when researchers and
policymakers fail to recognize how patient and family communi-
ties share and process information. For example, making sure
messages about evidence are workable for less traditional
dissemination approaches, such as social media, need to be
explored. Similarly, patients and families often look for ways that
evidence can guide speciﬁc actions. Partnerships with patients can
help develop systems to translate and clearly communicate
evidence in accessible ways that identify implications for possible
patient and caregiver actions without losing the nuances of the
evidence itself. This may require more active involvement in the
translation process than providing reviews of developed materials;
patient and families might serve as co-translators and even co-
strategists in thinking about how evidence can better guide patient
decisions. It is also important to remember that patients and
families often confuse general information and even individual
experiences of fellow patients with actual research evidence [28].
Organizational factors also inﬂuence engagement. Many orga-
nizations rest on foundations of provider-centric perspectives of
care, and there are often policies and practices that disable patient
partnerships or hinder their capacity. For example, feedback from
PCORI’s pilot research projects suggested that, for many academic
research centers, creating research partnerships with patients
requires signiﬁcant organizational change to move from viewing
patients only as research subjects [17]. Similar barriers were noted
in a recent PCORI survey of researchers [29]. As a result,
organizations have had to restructure to enable patient-partner
access to ﬁles, ﬁnancial arrangements, and other issues. And, there
may be resistance from organization leaders to the cost anddisruption of re-engineering key systems to enable patient-
consumer partnerships.
Finally, there are societal factors inﬂuencing engagement,
including far-reaching social norms about patient and caregiver
roles. Traditional societal values in healthcare tend to focus on
power. It is inaccurate to assume that a reversal of power from the
clinician, researcher, or policymaker to the consumer (“the
customer is always right”) is any more advantageous in a
partnership paradigm than the traditional power held by and
granted to health professionals. For patient and consumer
engagement to become standard practice across healthcare levels,
cultural and societal values—particularly where power differences
are maximized rather than minimized—must shift to support
mutually satisfying collaboration.
6. Pathways to patient partners who create and embrace
research evidence
Recognition of these factors enables research organizations
working with patient partners to consider pathways likely to
enhance the creation and use of research evidence as a tool for
improving individual and collective care and health. In an effort to
identify clear and distinct pathways for engagement, we convened
a group of 70 patients, clinicians, researchers, funders, payers,
administrators, and policymakers to create a Roadmap for Patient
and Family Engagement for the Moore Foundation (available at
www.patientfamilyengagement.org) [5]. Informed by years of
research and practice in patient engagement, the Roadmap
identiﬁes eight strategies to build meaningful partnerships with
patients and consumers across all healthcare endeavors, including
research.
Four strategies seem especially appropriate as a starting point
for organizations wishing to fully engage patients and consumers
in creating and using research evidence:
6.1. Patient and family preparation
Certainly, pathways to improve patient and consumer capacity
to participate across all phases of research require focused efforts
to prepare patients and consumers for these roles. This includes
easy-to-follow, plain language training programs, along with
consistent one-to-one communication with partners. Similarly,
broader population-based efforts are needed to help the public
distinguish research evidence from other forms of health
information and to become discerning consumers of research
ﬁndings.
6.2. Researcher, clinician, and administrator preparation
Preparing health professionals to work as partners with
patients and consumers is equally critical. Preparation may include
training and mentoring on subjects from understanding the
patient/consumer perspective and interests to modifying commu-
nication style for better interactions with partners. Health
professionals must develop clear goals and roles for the partner-
ship and consider how to share leadership.
6.3. Care, Policy, and Process Redesign
As mentioned earlier, organizational barriers to patient and
consumer partnership must be recognized and addressed. These
can range from changing meeting times and locations to
accommodate patient and consumer needs to expanding institu-
tional review board policies to include patients and consumers as
partners.
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Among the most critical pathways to increased use of research
evidence and evidence-based partnerships is greater public
transparency of the biomedical research enterprise, including its
structure, goals, processes, and funding mechanisms. From how
research priorities are determined and funded to how scientiﬁc
integrity is maintained, transparency can demystify the work and
bridge the traditional divide between expert and layperson.
Likewise, accountability by patient groups, funders, and govern-
ment for better patient partnerships can accelerate needed
changes.
7. Conclusion
As the conceptual model of patient engagement suggests,
relationships between patients and health professionals should
strive for full partnership and shared leadership. Narrowing the
separation of technical experts from laypersons through speciﬁc
strategies is critical to such partnerships growing and ﬂourishing.
Engaging patients in the planning, design, interpretation, and
dissemination of research can potentially produce more useful
evidence for consumers, not just in making individual decisions
about diagnosis or treatment, but in working alongside providers,
payers, and policymakers in applying the best evidence to build
safe, high-quality and efﬁcient systems of care.
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